tiprankstipranks
COSMO Pharmaceuticals N.V. (CH:COPN)
:COPN
Switzerland Market

COSMO Pharmaceuticals N.V. (COPN) Income Statement

Compare
0 Followers

COSMO Pharmaceuticals N.V. Income Statement

Last quarter (Q2 2024), COSMO Pharmaceuticals N.V.'s total revenue was €136.24M, an increase of 228.19% from the same quarter last year. In Q2, COSMO Pharmaceuticals N.V.'s net income was €75.99M. See COSMO Pharmaceuticals N.V.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 92.78M€ 102.09M€ 65.07M€ 60.95M€ 62.49M
Gross Profit
€ 53.44M€ 83.33M€ 49.93M€ 50.51M€ 53.25M
Operating Expenses
€ 47.29M€ 55.27M€ 38.83M€ 43.60M€ 65.56M
Depreciation and Amortization
€ 13.55M€ 13.86M€ 7.37M€ 6.04M€ 5.75M
EBITDA
€ 19.70M€ 47.49M€ 40.48M€ 7.84M€ -7.02M
Operating Income
€ 6.15M€ 28.06M€ 33.11M€ 2.06M€ -12.31M
Other Income/Expenses
€ -4.61M€ -3.58M€ -9.11M€ -13.84M€ -9.00M
Pretax Income
€ 1.53M€ 24.47M€ 24.00M€ -6.93M€ -21.30M
Net Income
€ -4.93M€ 17.23M€ 21.67M€ -7.90M€ -24.49M
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ -0.31€ 1.05€ 1.29€ -0.55€ -1.67
Diluted EPS
€ -0.31€ 1.05€ 1.28€ -0.55€ -1.67
Weighted Average Shares Outstanding
16.11M 16.43M 16.84M 14.47M 14.63M
Weighted Average Shares Outstanding (Diluted)
16.11M 16.43M 16.90M 14.47M 14.63M
Currency in EUR

COSMO Pharmaceuticals N.V. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis